Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Mayo Clinic
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Gloria M. Petersen, Mayo Clinic Identifier:
First received: January 31, 2009
Last updated: September 12, 2016
Last verified: September 2016

RATIONALE: Collecting and storing samples of blood and tissue from family members of patients with cancer to test in the laboratory may help the study of cancer in the future.

PURPOSE: This clinical trial is collecting blood and tissue samples from family members of patients with pancreatic disease, pancreatic cancer, and melanoma.

Condition Intervention
Familial Pancreatic Cancer
Other: biologic sample preservation procedure
Other: medical chart review
Other: survey administration

Study Type: Observational
Study Design: Observational Model: Family-Based
Time Perspective: Prospective
Official Title: Biospecimen Resource for Familial Pancreas Research, a Data and Tissue Registry (Also Known as a Bio-repository, Bio-bank, Data and Tissue Database, Data and Tissue Bank, Etc.) to Help Advance Research in Familial Pancreas Disease

Resource links provided by NLM:

Further study details as provided by Mayo Clinic:

Primary Outcome Measures:
  • Collection of familial data and biospecimens in a data and tissue repository for familial pancreas research [ Time Frame: baseline ]

Biospecimen Retention:   Samples With DNA
Two 10mL plasma tubes and two 10mL serum tubes collected. DNA extracted from blood lymphocytes. Possible saliva sample for DNA extraction. Waste tissue from previous surgery may be requested.

Estimated Enrollment: 4000
Study Start Date: August 2002
Estimated Study Completion Date: September 2017
Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: biologic sample preservation procedure
    one blood sample or saliva sample collection
    Other: medical chart review
    confirmation of cancer diagnosis
    Other: survey administration
    at baseline enrollment and 12 months post-enrollment
Detailed Description:


  • To collect clinical history, family history, and blood and/or tissue samples from family members of patients diagnosed with pancreatic diseases, pancreatic cancer, or melanoma.
  • To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic cancer, or other cancers.

OUTLINE: Study participants undergo collection of blood and/or tissue samples as well as survey data for inclusion in a familial data and tissue registry. Participants complete two baseline surveys regarding their personal, family, health, and environmental exposure histories and regarding their opinions on cancer and cancer screening. Patients also complete a follow-up survey at 1 year and undergo review of their medical records.


Ages Eligible for Study:   18 Years to 120 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Familial pancreatic cancer kindred


  • Meets 1 of the following criteria:

    • Has at least 2 blood relatives with pancreatic cancer (both must be related)
    • Has at least 1 blood relative with pancreatic cancer and 1 with melanoma (both must be related)


  • Mentally competent and able to provide informed consent
  • Able to understand and read English


  • Not specified
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00835133

Contact: Bridget Eversman 1-800-914-7962
Contact: Sarah Amundson 1-800-914-7962

United States, Minnesota
Mayo Clinic Cancer Center Recruiting
Rochester, Minnesota, United States, 55905
Contact: Clinical Trials Office - All Mayo Clinic Locations    507-538-7623      
Sponsors and Collaborators
Mayo Clinic
National Cancer Institute (NCI)
Principal Investigator: Gloria M. Petersen, PhD, FACMG Mayo Clinic
  More Information

Responsible Party: Gloria M. Petersen, PhD, Mayo Clinic Identifier: NCT00835133     History of Changes
Other Study ID Numbers: 355-06
R01CA097075-08 ( US NIH Grant/Contract Award Number )
CDR0000613097 ( Registry Identifier: NCI )
Study First Received: January 31, 2009
Last Updated: September 12, 2016

Keywords provided by Mayo Clinic:

Additional relevant MeSH terms:
Pancreatic Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Endocrine Gland Neoplasms
Digestive System Diseases
Pancreatic Diseases
Endocrine System Diseases
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Gastrointestinal Agents processed this record on April 26, 2017